Clinical trial
A Multi-Center, Prospective, Open-label Study Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Lower Extremity Ulcers
NCT07862335 is registered in ClinicalTrials.gov with Tiger Biosciences, LLC. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Prospective, Open-label Study Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Lower Extremity Ulcers
- Lead sponsor
- Tiger Biosciences, LLC.
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- June 30, 2027
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chronic ulcers, lower extremity, pressure ulcer (pu), venous leg ulcer (vlu), wound management